Trandafir , Paula CameliaTrandafir , Paula Camelia

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43636]], camposKey:2211-6753 2024-01-01 A criterion and incremental design construction for simultaneous kriging predictions116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43544]], camposKey:0929-693X 2024-01-01 Body composition and resting energy expenditure in a group of children with achondroplasia: Effectiveness of predictive models in the treatment of obesity129135, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43609]], camposKey:1885-0219 2024-01-01 La inteligencia emocional en el Grado de Enfermería15, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42233]], camposKey:0719-6946 2022-01-01 The perception and management of emotions in nursing students under clinical training1932, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40473]], camposKey:0363-3624 2021-01-01 A Teaching Experience Aimed at Health Professionals During the Second Wave Pandemic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)3232, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39183]], camposKey:1471-2458 2020-01-01 Space-time analysis of ovarian cancer mortality rates by age groups in spanish provinces (1989-2015)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39162]], camposKey:0364-216X 2020-01-01 Use of Symmetry Assessment Methods in the Context of Breast Surgery14401451, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37233]], camposKey:2013-5246 2018-01-01 The study of health-related quality of life using PDQ39 in patients with Parkinson's disease treated with advanced therapies [Estudio de calidad de vida con la PDQ39 en pacientes con enfermedad de Parkinson tratados con terapias avanzadas]914, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=36714]], camposKey:1432-2994 2018-01-01 Variants of the epsilon-constraint method for biobjective integer programming problems: application to p-median-cover problems251283, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=33364]], camposKey:0167-7152 2013-01-01 Optimal target allocation proportion for correlated binary responses in a 2 × 2 setup19911997, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=33366]], camposKey:0377-2217 2012-01-01 Some heuristic methods for solving p-median problems with a coverage constraint320327, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41813]], camposKey:0378-3758 2008-01-01 Optimal designs for discriminating between some extensions of the Michaelis Menten model37973804, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41814]], camposKey:0035-9246 2007-01-01 An optimal experimental design criterion for discriminating between non-normal models231242][][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=14793],camposKey=36-5981-555-1Optimal Experimental Designs for Pharmacokinetic Models 1 2016-01-01 LAP Lambert Academic Publishing}][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=4167]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@32ea8cae, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@38551e47, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7a0bb47, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@446a18ad, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@22037372, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3234f653, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@30cc19d1][][][][][][][][][][][][][][][][][]